vs
IRIDEX CORP（IRIX）与Laird Superfood, Inc.（LSF）财务数据对比。点击上方公司名可切换其他公司
IRIDEX CORP的季度营收约是Laird Superfood, Inc.的1.1倍（$14.7M vs $13.3M），Laird Superfood, Inc.同比增速更快（15.0% vs -69.7%），过去两年Laird Superfood, Inc.的营收复合增速更高（16.1% vs 11.9%）
IRIDEX Corporation是一家全球性医疗科技企业，主要研发、生产和销售面向眼科及医疗美容领域的激光类医疗设备，产品供应至北美、欧洲、亚太等地区的医疗机构与诊所，为眼部疾病治疗和医美项目提供微创解决方案。
Laird Superfood是一家主营植物基功能性超级食品的企业，产品涵盖精品咖啡奶精、补水混合饮品、营养补充剂、植物能量零食等，面向健康意识较强的消费群体，主要在北美市场通过电商及线下零售渠道销售，主打可持续采购的清洁配方。
IRIX vs LSF — 直观对比
营收规模更大
IRIX
是对方的1.1倍
$13.3M
营收增速更快
LSF
高出84.8%
-69.7%
两年增速更快
LSF
近两年复合增速
11.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $14.7M | $13.3M |
| 净利润 | — | $-1.8M |
| 毛利率 | 37.2% | 34.1% |
| 营业利润率 | — | -13.5% |
| 净利率 | — | -13.2% |
| 营收同比 | -69.7% | 15.0% |
| 净利润同比 | — | -341.4% |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IRIXLSF
| Q4 25 | $14.7M | $13.3M | ||
| Q3 25 | $12.5M | $12.9M | ||
| Q2 25 | $13.6M | $12.0M | ||
| Q1 25 | $11.9M | $11.7M | ||
| Q4 24 | $12.7M | $11.6M | ||
| Q3 24 | $11.6M | $11.8M | ||
| Q2 24 | $12.6M | $10.0M | ||
| Q1 24 | $11.8M | $9.9M |
净利润IRIXLSF
| Q4 25 | — | $-1.8M | ||
| Q3 25 | $-1.6M | $-975.1K | ||
| Q2 25 | $-994.0K | $-362.2K | ||
| Q1 25 | $-1.7M | $-156.2K | ||
| Q4 24 | $-834.0K | $-398.4K | ||
| Q3 24 | $-1.9M | $-166.1K | ||
| Q2 24 | $-2.7M | $-239.1K | ||
| Q1 24 | $-3.5M | $-1.0M |
毛利率IRIXLSF
| Q4 25 | 37.2% | 34.1% | ||
| Q3 25 | 32.1% | 36.5% | ||
| Q2 25 | 34.5% | 39.9% | ||
| Q1 25 | 42.5% | 41.9% | ||
| Q4 24 | 44.0% | 38.6% | ||
| Q3 24 | 37.3% | 43.0% | ||
| Q2 24 | 40.7% | 41.8% | ||
| Q1 24 | 37.9% | 40.0% |
营业利润率IRIXLSF
| Q4 25 | — | -13.5% | ||
| Q3 25 | -11.3% | -7.7% | ||
| Q2 25 | -6.9% | -3.3% | ||
| Q1 25 | -1.7% | -1.9% | ||
| Q4 24 | -3.9% | -4.1% | ||
| Q3 24 | -16.1% | -2.3% | ||
| Q2 24 | -20.9% | -3.4% | ||
| Q1 24 | -28.0% | -11.0% |
净利率IRIXLSF
| Q4 25 | — | -13.2% | ||
| Q3 25 | -12.6% | -7.6% | ||
| Q2 25 | -7.3% | -3.0% | ||
| Q1 25 | -14.2% | -1.3% | ||
| Q4 24 | -6.6% | -3.4% | ||
| Q3 24 | -16.7% | -1.4% | ||
| Q2 24 | -21.2% | -2.4% | ||
| Q1 24 | -29.5% | -10.3% |
每股收益（稀释后）IRIXLSF
| Q4 25 | — | — | ||
| Q3 25 | $-0.09 | — | ||
| Q2 25 | $-0.06 | — | ||
| Q1 25 | $-0.10 | — | ||
| Q4 24 | $-0.05 | — | ||
| Q3 24 | $-0.12 | — | ||
| Q2 24 | $-0.16 | — | ||
| Q1 24 | $-0.21 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.0M | $5.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $11.5M |
| 总资产 | $29.2M | $19.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IRIXLSF
| Q4 25 | $6.0M | $5.1M | ||
| Q3 25 | $5.6M | $5.1M | ||
| Q2 25 | $6.8M | $3.9M | ||
| Q1 25 | $7.2M | $7.0M | ||
| Q4 24 | $2.4M | $8.3M | ||
| Q3 24 | $3.9M | $7.9M | ||
| Q2 24 | $4.1M | $7.6M | ||
| Q1 24 | $5.4M | $7.1M |
总债务IRIXLSF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.0M | — | ||
| Q3 24 | $1.4M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益IRIXLSF
| Q4 25 | — | $11.5M | ||
| Q3 25 | $4.7M | $12.8M | ||
| Q2 25 | $6.1M | $13.4M | ||
| Q1 25 | $852.0K | $13.3M | ||
| Q4 24 | $2.1M | $13.2M | ||
| Q3 24 | $2.6M | $13.1M | ||
| Q2 24 | $4.2M | $12.6M | ||
| Q1 24 | $6.5M | $12.7M |
总资产IRIXLSF
| Q4 25 | $29.2M | $19.2M | ||
| Q3 25 | $28.4M | $18.9M | ||
| Q2 25 | $31.6M | $20.4M | ||
| Q1 25 | $34.2M | $21.5M | ||
| Q4 24 | $29.1M | $19.3M | ||
| Q3 24 | $30.2M | $18.8M | ||
| Q2 24 | $31.2M | $18.0M | ||
| Q1 24 | $34.1M | $17.6M |
负债/权益比IRIXLSF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.48× | — | ||
| Q3 24 | 0.53× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $68.4K |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流IRIXLSF
| Q4 25 | — | $68.4K | ||
| Q3 25 | $-1.2M | $1.2M | ||
| Q2 25 | $-397.0K | $-2.8M | ||
| Q1 25 | $-1.1M | $-1.3M | ||
| Q4 24 | $-1.2M | $339.2K | ||
| Q3 24 | $-3.1M | $305.8K | ||
| Q2 24 | $-1.3M | $642.7K | ||
| Q1 24 | $-1.6M | $-422.3K |
自由现金流IRIXLSF
| Q4 25 | — | — | ||
| Q3 25 | $-1.2M | — | ||
| Q2 25 | $-410.0K | — | ||
| Q1 25 | $-1.2M | — | ||
| Q4 24 | $-1.2M | — | ||
| Q3 24 | $-3.1M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-1.7M | — |
自由现金流率IRIXLSF
| Q4 25 | — | — | ||
| Q3 25 | -9.4% | — | ||
| Q2 25 | -3.0% | — | ||
| Q1 25 | -9.8% | — | ||
| Q4 24 | -9.8% | — | ||
| Q3 24 | -26.5% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -14.0% | — |
资本支出强度IRIXLSF
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IRIX
暂无分部数据
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
